FC
ANIK icon

FORA Capital’s Anika Therapeutics ANIK Stock Holding History

FORA Capital’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,067
Closed -$40K – 647
2020
Q2 		$40K Sell
1,067
-389
-27% -$12.8K 0.01% 685
2020
Q1 		$42K Buy
+1,456
New +$58.9K 0.01% 801

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

FORA Capital's ANIK Position: Q3 2020 in Review

FORA Capital sold out of Anika Therapeutics (ANIK) in Q3 2020, closing a stake of 1,067 shares — an estimated $40K sold.

FORA Capital first reported a position in ANIK in Q1 2020 and held it in 2 quarters. The position peaked at $42K in Q1 2020. 156 funds tracked by Wall St. Rank hold ANIK as of Q3 2020.

  • FORA Capital reported no remaining Anika Therapeutics position as of Q3 2020 after selling out during the quarter.
  • FORA Capital sold 1,067 Anika Therapeutics shares in Q3 2020, an estimated $40K.
  • FORA Capital first reported a position in Anika Therapeutics in Q1 2020 and held it in 2 quarters.
  • FORA Capital's Anika Therapeutics position peaked at $42K in Q1 2020.
  • 156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2020.

Based on FORA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.